A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-10-09
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Theranexus
- Target Recruit Count
- 152
- Registration Number
- NCT03698695
- Locations
- 🇫🇷
CHU Grenoble, Grenoble, France
🇫🇷CHU Bordeaux, Bordeaux, France
🇫🇷CHU Clermont Ferrand, Clermont-Ferrand, France
Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-08-10
- Last Posted Date
- 2020-12-01
- Lead Sponsor
- Theranexus
- Target Recruit Count
- 77
- Registration Number
- NCT03624920
- Locations
- 🇺🇸
MGH Neurological Clinical Research Institute, Boston, Massachusetts, United States
🇨🇿Institut neuropsychiatrické péče, Praga 8, Czechia
🇨🇿Axon Clinical, s.r.o., Praha 5, Czechia
Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation
- First Posted Date
- 2017-06-09
- Last Posted Date
- 2017-06-09
- Lead Sponsor
- Theranexus
- Target Recruit Count
- 20
- Registration Number
- NCT03182413
Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients
- First Posted Date
- 2016-07-01
- Last Posted Date
- 2020-09-04
- Lead Sponsor
- Theranexus
- Target Recruit Count
- 51
- Registration Number
- NCT02821715
- Locations
- 🇫🇷
CHU Pellegrin, Bordeaux, France
🇧🇪RespiSom, Erpent, Belgium
🇫🇷CHU Dijon Bourgogne, Dijon, France
© Copyright 2024. All Rights Reserved by MedPath